Wordt geladen...
Comparison of outcomes following a switch from a brand to an authorized vs. independent generic drug
Authorized generics are identical in formulation to brand drugs, manufactured by the brand company but marketed as a generic. Generics, marketed by generic manufacturers, are required to demonstrate pharmaceutical and bioequivalence to the brand drug, but repetition of clinical trials is not require...
Bewaard in:
| Gepubliceerd in: | Clin Pharmacol Ther |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5860648/ https://ncbi.nlm.nih.gov/pubmed/27981563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.591 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|